Bixiye
QP81-21 Save the Date: Best Practices in Value-Based Arrangements
Taariikhda uu dhaqangalayo barnaamijka: Okt 27, 2021
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1851 - 1860 ee natiijooyinka 3563
Bixiye
QP82-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Accrufer™ (ferric maltol)
Taariikhda uu dhaqangalayo barnaamijka: Okt 27, 2021
Bixiye
QP83-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Kerendia®
Taariikhda uu dhaqangalayo barnaamijka: Okt 27, 2021
Bixiye
QP84-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Cholestasis Pruritis
Taariikhda uu dhaqangalayo barnaamijka: Okt 27, 2021
Bixiye
QP85R1-21 Resolution Process for Providers Serving Minnesota Health Care Programs (MHCP) Members
Taariikhda uu dhaqangalayo Barnaamijka: May 11, 2022
Diiwaangelinta & Qalmida
Pay-It Easy Automatic Premium Payment Program Enrollment Form
Bixiye
QP76-21 Commercial and MHCP Pharmacy Benefit Exclusion for Uptravi®
Taariikhda uu dhaqangalayo barnaamijka: Okt 13, 2021
Bixiye
QP77-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective December 1, 2021
Taariikhda uu dhaqangalayo barnaamijka: Okt 13, 2021
Bixiye
QP78-21 Commercial Pharmacy Benefit Update – New Drug-Related Quantity Limit (QL) Criteria: Stromectol® (ivermectin)
Taariikhda uu dhaqangalayo barnaamijka: Okt 13, 2021